Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity

por Pecankova, Klara, Cermak, Jaroslav, Majek, Pavel
Publicado 2022

Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome

por Pecankova, Klara, Majek, Pavel, Cermak, Jaroslav, Dyr, Jan E.
Publicado 2015

Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups

por Majek, Pavel, Pecankova, Klara, Cermak, Jaroslav, Dyr, Jan E.
Publicado 2015

Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients

por Pecankova, Klara, Majek, Pavel, Cermak, Jaroslav, Dyr, Jan E.
Publicado 2017

Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia

por Májek, Pavel, Reicheltová, Zuzana, Suttnar, Jiří, Čermák, Jaroslav, Dyr, Jan E
Publicado 2011

Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome

por Májek, Pavel, Reicheltová, Zuzana, Suttnar, Jiří, Čermák, Jaroslav, Dyr, Jan E
Publicado 2012

Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome

por Májek, Pavel, Riedelová-Reicheltová, Zuzana, Suttnar, Jiří, Pečánková, Klára, Čermák, Jaroslav, Dyr, Jan E
Publicado 2013

Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome

por Štikarová, Jana, Suttnar, Jiří, Pimková, Kristýna, Chrastinová-Mášová, Leona, Čermák, Jaroslav, Dyr, Jan E
Publicado 2013

Proteome Changes in the Plasma of Myelodysplastic Syndrome Patients with Refractory Anemia with Excess Blasts Subtype 2

por Majek, Pavel, Riedelova-Reicheltova, Zuzana, Suttnar, Jiri, Pecankova, Klara, Cermak, Jaroslav, Dyr, Jan E.
Publicado 2014

Differential Expression of MicroRNAs in CD34+ Cells of 5q- Syndrome

por Votavova, Hana, Grmanova, Martina, Dostalova Merkerova, Michaela, Belickova, Monika, Vasikova, Alzbeta, Neuwirtova, Radana, Cermak, Jaroslav
Publicado 2011

Plasma Levels of Aminothiols, Nitrite, Nitrate, and Malondialdehyde in Myelodysplastic Syndromes in the Context of Clinical Outcomes and as a Consequence of Iron Overload

por Pimková, Kristýna, Chrastinová, Leona, Suttnar, Jiří, Štikarová, Jana, Kotlín, Roman, Čermák, Jaroslav, Dyr, Jan Evangelista
Publicado 2014

Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome

por Pecankova, Klara, Pecherkova, Pavla, Gasova, Zdenka, Sovova, Zofie, Riedel, Tomas, Jäger, Eliézer, Cermak, Jaroslav, Majek, Pavel
Publicado 2022

Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients

por Votavova, Hana, Urbanova, Zuzana, Kundrat, David, Dostalova Merkerova, Michaela, Vostry, Martin, Hruba, Monika, Cermak, Jaroslav, Belickova, Monika
Publicado 2021

Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia...

por Merkerova, Michaela Dostalova, Remesova, Hana, Krejcik, Zdenek, Loudova, Nikoleta, Hrustincova, Andrea, Szikszai, Katarina, Cermak, Jaroslav, Jonasova, Anna, Belickova, Monika
Publicado 2018

DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population

por Belickova, Monika, Merkerova, Michaela Dostalova, Stara, Eliska, Vesela, Jitka, Sponerova, Dana, Mikulenkova, Dana, Brdicka, Radim, Neuwirtova, Radana, Jonasova, Anna, Cermak, Jaroslav
Publicado 2013

Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagno...

por Arthur, Christopher, Cermak, Jaroslav, Delaunay, Jacques, Mayer, Jiří, Mazur, Grzegorz, Thomas, Xavier, Wierzbowska, Agnieszka, Jones, Mark M, Berrak, Erhan, Kantarjian, Hagop
Publicado 2015

Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations

por Bodó, Imre, Amine, Ismail, Boban, Ana, Bumbea, Horia, Kulagin, Alexander, Lukina, Elena, Piekarska, Agnieszka, Zupan, Irena Preloznik, Sokol, Juraj, Windyga, Jerzy, Cermak, Jaroslav
Publicado 2023

TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes

por Belickova, Monika, Vesela, Jitka, Jonasova, Anna, Pejsova, Barbora, Votavova, Hana, Merkerova, Michaela Dostalova, Zemanova, Zuzana, Brezinova, Jana, Mikulenkova, Dana, Lauermannova, Marie, Valka, Jan, Michalova, Kyra, Neuwirtova, Radana, Cermak, Jaroslav
Publicado 2016

A New Approach for the Diagnosis of Myelodysplastic Syndrome Subtypes Based on Protein Interaction Analysis

por Chrastinová, Leona, Pastva, Ondřej, Bocková, Markéta, Lynn, Nicholas S., Šácha, Pavel, Hubálek, Martin, Suttnar, Jiří, Kotlín, Roman, Štikarová, Jana, Hlaváčková, Alžběta, Pimková, Kristýna, Čermák, Jaroslav, Homola, Jiří, Dyr, Jan E.
Publicado 2019

LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome

por Szikszai, Katarina, Krejcik, Zdenek, Klema, Jiri, Loudova, Nikoleta, Hrustincova, Andrea, Belickova, Monika, Hruba, Monika, Vesela, Jitka, Stranecky, Viktor, Kundrat, David, Pecherkova, Pavla, Cermak, Jaroslav, Jonasova, Anna, Dostalova Merkerova, Michaela
Publicado 2020